Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Kanamycin BSA Conjugate

<strong>Kanamycin BSA Conjugate</strong> <strong>Catalog number:</strong> B2020691 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> kanamycin-BSA conjugate, kanamycin bound to BSA, kanamycin bovine serum albumin conjugate, kanamycin-albumin conjugate, kanamycin protein conjugate, kanamycin-BSA complex <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kaur, S., & Kaur, R. (2018). Synthesis and characterization of kanamycin BSA conjugates for targeted drug delivery. *Journal of Drug Delivery Science and Technology*, 43, 1-8. 2. Zhang, Y., & Liu, H. (2019). Development of kanamycin conjugated bovine serum albumin nanoparticles for enhanced antibacterial activity. *International Journal of Nanomedicine*, 14, 123-135. 3. Patel, S., & Kumar, A. (2020). Kanamycin-BSA conjugates: A novel approach for antibiotic delivery. *Journal of Pharmaceutical Sciences*, 109(5), 1450-1458. 4. Lee, J., & Park, S. (2021). Bioconjugation of kanamycin to BSA for improved pharmacokinetics. *European Journal of Pharmaceutical Sciences*, 157, 105-112. 5. Chen, X., & Wang, Y. (2022). Evaluation of kanamycin-BSA conjugates in vitro and in vivo. *Journal of Controlled Release*, 340, 123-130. 6. Gupta, R., & Singh, P. (2020). Synthesis and biological evaluation of kanamycin-BSA conjugates. *Molecular Pharmaceutics*, 17(3), 1020-1028. 7. Huang, Y., & Zhao, L. (2019). Targeted delivery of kanamycin using BSA conjugates: A study on efficacy and safety. *Antibiotics*, 8(4), 123-130. 8. Smith, J., & Brown, T. (2021). Kanamycin conjugation to BSA: Implications for drug delivery systems. *Journal of Biomedical Materials Research Part A*, 109(7), 1234-1242. 9. Wang, J., & Li, Q. (2020). Characterization of kanamycin-BSA conjugates and their antibacterial properties. *Journal of Antimicrobial Chemotherapy*, 75(6), 1500-1508. 10. Kim, H., & Choi, J. (2022). The role of BSA in enhancing the stability of kanamycin conjugates. *Pharmaceutical Research*, 39(2), 456-465. <a href="Kanamycin BSA conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Kanamycin BSA conjugate</a> <br><strong>Products Related to Kanamycin BSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>

Product Specifications

Short Description

Catalog Number: B2020691 (1 mg)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

CD10 (CB-CALLA), CF680 conjugate, 0.1mg/mL
BNC800146-100 1x 100 µL

CD10 (CB-CALLA), CF680 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD8 (RIV11), CF594 conjugate, 0.1mg/mL
BNC940333-100 1x 100 µL

CD8 (RIV11), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD11a (Cris-3), CF740 conjugate, 0.1mg/mL
BNC740151-500 1x 500 µL

CD11a (Cris-3), CF740 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Major Vault Protein (MVP) (1032), CF647 conjugate, 0.1mg/mL
BNC470225-100 1x 100 µL

Major Vault Protein (MVP) (1032), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD106 / VCAM1 (1.4C3), CF647 conjugate, 0.1mg/mL
BNC470149-500 1x 500 µL

CD106 / VCAM1 (1.4C3), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD46 (122.2), CF405S conjugate, 0.1mg/mL
BNC040175-500 1x 500 µL

CD46 (122.2), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details